|
News for Healthier Living
Immunotherapy Boosts Chemotherapy in Combating Stage 3 Colon Cancer
New research led by Mayo Clinic Comprehensive Cancer Center found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer -- and with a specific genetic makeup called deficient DNA mismatch repair (dMMR) -- was associated with a 50% reduction in cancer recurrence and death compared to chemotherapy alone.
June 1, 2025
June 14 2025June 13 2025June 12 2025June 11 2025June 10 2025June 9 2025June 8 2025June 7 2025June 6 2025June 5 2025June 4 2025June 3 2025June 2 2025June 1 2025
|
|
|
|
|